Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06590805

Electroacupoint for Diminutive Milk Production

Ameliorative Potential of Electroacupoint for Diminutive Milk Production in Lactating Woman

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
Haytham Ibrahim Morsi · Academic / Other
Sex
Female
Age
25 Years – 30 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.

Detailed description

Postnatal scanty milk secretion is a common complaint. Some physical and medicinal therapies have been proposed to enhance milk production. These therapies must be both successful and safe for both the mother and the child. In many cases, milk supply can be increased by frequent, regular milk removal, Medication to increase milk supply (galactogogues) such as domperidone. Domperidone has been linked to maternal adverse effects in galactogogue trials and cases reported to the Food and Drug Administration include dry mouth, headache, dizziness, nausea, abdominal cramping, diarrhea, palpitations malaise, and shortness of breath. Some of these were more frequent with dosages greater than with 30 mg daily. Drug withdrawal symptoms consisting of insomnia, anxiety, and tachycardia were reported in a woman taking 80 mg of domperidone daily for 8 months as a galactogogue who abruptly tapered the dose over 3 days.

Conditions

Interventions

TypeNameDescription
PROCEDUREElectrotherapy using Chattanooga stimulation unitElectroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.
DIETARY_SUPPLEMENTBalanced Diet using domperidone drug, iron, and folic acid supplementation.Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care. It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.

Timeline

Start date
2024-09-01
Primary completion
2025-01-01
Completion
2025-06-01
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06590805. Inclusion in this directory is not an endorsement.